Growing Stroke and Brain Aneurysm Burden in Older Adults
Stroke is a leading cause of death and disability worldwide — with ischemic strokes comprising a majority — and is prevalent in BRICS countries due to demographic aging, rising prevalence of hypertension, diabetes, and lifestyle risk factors. China, India, and Brazil contribute a significant share of global stroke cases with large patient volumes presenting for emergency neurovascular interventions. Neurovascular catheters are essential in mechanical thrombectomy procedures to navigate tortuous cerebral vessels, retrieve clots, and restore blood flow, improving chances of recovery when administered rapidly.
Cerebral aneurysms, often asymptomatic until rupture, are more frequently identified due to improved access to diagnostic imaging, especially in urban centers. Endovascular treatments such as coil embolization and flow diversion demand microcatheter systems for precise device delivery. Hospitals in China and India are making strategic investments in tertiary care facilities to provide these minimally invasive treatments. The rising procedural volumes for both stroke and aneurysm management have elevated demand for specialized catheters with enhanced flexibility, trackability, and biocompatibility.
With expanding awareness campaigns, government healthcare spending, and increasing access to emergency neurology services, BRICS countries are witnessing consistent procedural growth. These factors drive sustained demand for neurovascular catheters across hospitals, clinics, and specialized neuro interventional centers throughout the region.
Strategic Alliances Between Medical Tech Firms and Hospitals
As neurovascular interventions become more complex and demand rises, hospitals in BRICS nations are seeking partnerships with device manufacturers to access advanced catheter technologies, specialized clinical training, and procedural support. These collaborations include long‑term supply agreements, co‑development initiatives, and integrated service models that tailor device portfolios to regional clinical needs.
For MedTech firms, engagement with leading hospitals and stroke centers in China, Brazil, and India provides insights into clinician preferences, procedural challenges, and opportunities for product innovation. This feedback loop enables the design of catheters with improved navigation, reduced friction, and compatibility with varied anatomical profiles prevalent across diverse patient populations. Hospitals benefit from early access to new catheter solutions, structured training programs for neuro interventional specialists, and on‑site procedural support.
Clinical research partnerships generate region‑specific evidence that bolsters regulatory approvals and inclusion in treatment guidelines, which are critical in markets with diverse reimbursement policies. Hospitals participating in collaborative studies become reference centers, catalyzing broader adoption of advanced catheter technologies within their healthcare networks. Commercially, collaborations with large hospital groups and government health systems provide MedTech firms with predictable procurement channels and deeper market penetration.
In emerging BRICS markets — particularly India and South Africa — where cost sensitivity and infrastructure variability exist, collaborations help address local training needs and device support requirements. As healthcare systems emphasize value‑based outcomes and minimally invasive care, these strategic partnerships will be central to expanding access to neurovascular catheter technologies and sustaining regional growth.
